Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
Sign Up to like & getrecommendations! Published in 2019 at "PLoS ONE"
DOI: 10.1371/journal.pone.0215109
Abstract: The original underlying data supporting results in this article are no longer available. The authors replicated the experiments for which concerns were raised using the same methods and conditions as in the original study [1].… read more here.
Keywords: activity sorafenib; sorafenib human; antitumor activity; expression concern ... See more keywords
In vivo inhibitory effect of suberoylanilide hydroxamic acid combined with sorafenib on human hepatocellular carcinoma cells
Sign Up to like & getrecommendations! Published in 2020 at "Brazilian Journal of Pharmaceutical Sciences"
DOI: 10.1590/s2175-97902019000318254
Abstract: The present study aimed to investigate the in vivo inhibitory effect of histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) combined with sorafenib on human hepatocellular carcinoma HCCLM3 cells. The nude mice transplanted with HCCLM3 cells… read more here.
Keywords: combined sorafenib; sorafenib human; hydroxamic acid; inhibitory effect ... See more keywords